Current information on candida

Keep Up To Date With Yeast Infection News

Merck & Co., Inc. Receives Complete Response Letter from the Food and Drug Administration for Use of GARDASIL® in ... (Business Wire via Yahoo! Finance)

Fri, 09 Jan 2009 13:39:00 GMT
WHITEHOUSE STATION, N.J.----Merck & Co., Inc. announced today that the U.S. Food and Drug Administration has issued a second complete response letter regarding the supplemental biologics license application for the use of GARDASIL® Human Papillomavirus Quadrivalent Vaccine, Recombinant ] in women ages 27 though 45.

Merck & Co., Inc. Receives Complete Response Letter from the Food and ... - MSN MoneyCentral

Fri, 09 Jan 2009 13:41:00 GMT
Merck & Co., Inc. announced today that the U.S. Food and Drug Administration has issued a second complete response letter regarding the supplemental biologics license application ...

Yeast infections